Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: August 2012
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar on "Supplemental Examination: Rules and Strategy" on September 18, 2012 beginning at 2:00 pm (ET). A panel consisting of Robert Bahr, Deputy Commissioner for Patent Examination Policy, USPTO; Courtenay Brinckerhoff of Foley & Lardner LLP; and Kurtis MacFerrin of Google, Inc. will discuss the…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar on "Inter Partes Review: Rules and Strategy" on September 5, 2012 beginning at 2:00 pm (ET). A panel consisting of the Hon. Sally Medley, Administrative Patent Judge, USPTO; Kevin Laurence of Stoel Rives, LLP; and Scott Markow of Stanley Black & Decker, Inc. will…
-
By Kevin E. Noonan — Earlier this year, the Supreme Court asked the Solicitor General for his views on whether the Court should grant certiorari in Bowman v. Monsanto. The Solicitor has now given the Court his views, and they are that the Court should not grant cert. Although the Court does not always follow…
-
By Craig Humphris & David McCarthy — Australia is attempting to raise its patentability threshold and specification requirements. Significant amendments have been made to Australia's patent laws through enactment of the Intellectual Property Laws Amendment (Raising the Bar) Act 2012. Most provisions will take effect from 15 April 2013. The Raising the Bar Act, which…
-
By Kevin E. Noonan — Last month, the Federal Trade Commission accomplished a decade-long goal: getting a Federal Circuit Court of Appeal (the 3rd Circuit) to support its position that so-called "reverse payments" (also known as "pay-for-delay" arrangements) between innovator pharmaceutical companies and generic drugmakers in ANDA litigation brought under 35 U.S.C. § 271(e)(2) are…
-
By Donald Zuhn — USPTO to Hold Roundtable on AIA First Inventor to File Provisions Earlier this month, the U.S. Patent and Trademark Office published a notice in the Federal Register (77 Fed. Reg. 49427) announcing that the Office will be hosting a roundtable on September 6, 2012 to obtain public input from organizations and…
-
By Kevin E. Noonan — A three judge Federal Circuit panel went a long way towards disentangling its jurisprudence on the question of obviousness-type double patenting, in affirming a District Court finding that the doctrine did not apply to the patent claims at issue in Eli Lilly & Co. v. Teva. In what seems to…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Merck Sharp & Dohme Corp. v. Watson Laboratories, Inc.3:12-cv-05228; filed August 20, 2012 in the District Court of New Jersey Infringement of U.S. Patent Nos. 5,571,817 ("Methods of Treating Androgenic Alopecia with Finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]," issued…
-
August 27, 2012 – AIA Post-Grant Implementation Begins – Is Your Business Strategy Aligned? (Foley & Lardner) – 3:00 pm (Eastern) August 30, 2012 – The Written Description Requirement: Are Antibodies Chemicals, Proteins, or Exceptions? (American Bar Association) – 1:00 – 2:30 pm (Eastern) September 6, 2012 – A Review of the Impact of Recent…
-
Strafford will be offering a webinar/teleconference entitled "New USPTO Rules for Post-Grant Proceedings: Meeting the New Requirements for Post-Grant and Inter Partes Reviews and Supplemental Examination" on September 18, 2012 from 1:00 – 2:30 pm (EDT). Scott A. McKeown, Greg H. Gardella, and Jessica J. Harrison of Oblon Spivak McClelland Maier & Neustadt will provide…
Patent Docs 